QMLGApr 23, 2020

MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction

arXiv:2004.11424v1522 citations
Originality Incremental advance
AI Analysis

This work addresses the problem of costly and time-consuming drug discovery for researchers by providing a more accurate and interpretable deep learning method, though it appears incremental as it builds on existing transformer and substructure-based approaches.

The paper tackled drug target interaction prediction by proposing MolTrans, a molecular interaction transformer that improved accuracy and interpretability through substructural pattern mining and an augmented transformer encoder, achieving better performance than state-of-the-art baselines on real-world data.

Drug target interaction (DTI) prediction is a foundational task for in silico drug discovery, which is costly and time-consuming due to the need of experimental search over large drug compound space. Recent years have witnessed promising progress for deep learning in DTI predictions. However, the following challenges are still open: (1) the sole data-driven molecular representation learning approaches ignore the sub-structural nature of DTI, thus produce results that are less accurate and difficult to explain; (2) existing methods focus on limited labeled data while ignoring the value of massive unlabelled molecular data. We propose a Molecular Interaction Transformer (MolTrans) to address these limitations via: (1) knowledge inspired sub-structural pattern mining algorithm and interaction modeling module for more accurate and interpretable DTI prediction; (2) an augmented transformer encoder to better extract and capture the semantic relations among substructures extracted from massive unlabeled biomedical data. We evaluate MolTrans on real world data and show it improved DTI prediction performance compared to state-of-the-art baselines.

Code Implementations1 repo
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes